FDA Clears Abbott Device for Minimally Invasive Heart Valve Leak Repair

AI-generated NewsSnap summary based on source reporting.
Published: 2026-10-28
Category: health
Source: Abbott MediaRoom
Original source

The FDA has approved Abbott's Amplatzer Paraclose PVL Occluder, a transcatheter device for treating paravalvular leaks. This marks the first U.S. approval for a minimally invasive option, offering an alternative to repeat open-heart surgery for patients experiencing blood backflow around surgical heart valves. It represents a significant advancement in cardiac care.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai